European Diabetes Leadership Forum Participation Report
date : 4/26/2012
HGPI Director Ryoji Noritake recently participated in the European Diabetes Leadership Forum, held on the 25-26 April 2012 in Denmark, the EU presidency holder country for the first half of 2012.
This forum was held as a meeting for high-level discussions on how diabetes control could act as a model case for progression in the area of chronic disease control. It aimed to reflect on the magnitude of the influence of diabetes prevalence in Europe, and hold discussions from the perspective of prevention, early detection, and improvement of treatment. The forum was organized by the Organization for Economic Co-operation and Development (OECD) together with the Danish Diabetes Association (DDA), with backing from the Danish government and Danish Health Ministry and support from the company Novo Nordisk. Around 760 people attended, with participants representing government, industry, academia, and patients present from all over the world, including EU Member States, European Free Trade Association Member States, EU non-member states, and OECD Member States.
Speeches were also made by the Danish Prime Minister and Minister of Health and Welfare, as well as Kofi Annan, former U.N. Secretary-General. The importance of comprehensive approaches which transcend health policy frameworks was emphasized, together with the importance of policies which bridge patient and multi-stakeholder involvement in prevention with treatment. Furthermore, it was also re-recognized that diabetes control does not just end with the formulation of a road map as actual implementation is also important, and to this end patient empowerment and cooperative activities between different sectors were highlighted as being additionally important.
This forum was held as a meeting for high-level discussions on how diabetes control could act as a model case for progression in the area of chronic disease control. It aimed to reflect on the magnitude of the influence of diabetes prevalence in Europe, and hold discussions from the perspective of prevention, early detection, and improvement of treatment. The forum was organized by the Organization for Economic Co-operation and Development (OECD) together with the Danish Diabetes Association (DDA), with backing from the Danish government and Danish Health Ministry and support from the company Novo Nordisk. Around 760 people attended, with participants representing government, industry, academia, and patients present from all over the world, including EU Member States, European Free Trade Association Member States, EU non-member states, and OECD Member States.
Speeches were also made by the Danish Prime Minister and Minister of Health and Welfare, as well as Kofi Annan, former U.N. Secretary-General. The importance of comprehensive approaches which transcend health policy frameworks was emphasized, together with the importance of policies which bridge patient and multi-stakeholder involvement in prevention with treatment. Furthermore, it was also re-recognized that diabetes control does not just end with the formulation of a road map as actual implementation is also important, and to this end patient empowerment and cooperative activities between different sectors were highlighted as being additionally important.
Exhibition date：2012-04-26
Top Research & Recommendations Posts
- [Policy Recommendations] Joint Statement “Protecting the Health of Both the Planet and People — A Japan-Model Planetary Health Strategy to Turn the Climate Crisis into an Opportunity for Health, the Economy, and Growth” (June 24, 2026)
- [Policy Recommendations] Toward Further Advancement of Measures Against Antimicrobial Resistance (AMR) (July 15, 2026)
- [Announcement] HGPI Joins the UHC2030 Task Force for the 2027 UN High-Level Meeting on UHC (July 6, 2026)
- [Research Report] Energy Conservation and Greenhouse Gas Emissions Reduction in Healthcare Facilities: Case Studies from New Construction and Facility Renewal (March 16, 2026)
- [Research Report] AMR Policy Update #6: The New Global Action Plan on AMR (Part 1)
- [Research Report] AMR Policy Update #7: The New Global Action Plan on AMR (Part 2)
- [Policy Recommendations] Hearing Loss Project “Recommendations on Coherent Countermeasures for Hearing Loss Throughout the Life Course: Building a Society Where Everyone Can Access Appropriate Hearing Care” (July 30, 2026)
- [Research Report] AMR Policy Update #9: Stockholm Residents’ Awareness and Practices in Returning and Recycling Pharmaceuticals: Findings from Local Interviews (July 15, 2026)
- [Policy Recommendations] Expectations for a System that Spans Diseases, Ministries, and Agencies for the Effective Promotion of Patient and Public Involvement (PPI) in Research and Development (June 30, 2026)
- [Activity Report] HGPI Contributed to the Development of the Civil 7 (C7) Global Health Working Group’s Climate and Health Thematic Brief for the G7 (June 25, 2026)
Featured Posts
-
2026-06-19
[Recommendations] Strengthening Epidemiology Education in the Veterinary Field for the One Health Era (June 19, 2026)
![[Recommendations] Strengthening Epidemiology Education in the Veterinary Field for the One Health Era (June 19, 2026)](https://hgpi.org/en/wp-content/uploads/sites/2/HGPI_eyecatch_20260619_AMR_Recommendations.png)
-
2026-07-21
[Announcement] Announcement of the 2nd Kiyoshi Kurokawa Award Recipient
![[Announcement] Announcement of the 2nd Kiyoshi Kurokawa Award Recipient](https://hgpi.org/en/wp-content/uploads/sites/2/Kiyoshi-Kurokawa-Award_2nd_eyecatch_web.jpg)
-
2026-07-22
[Registration Open] Second Session of the Planetary Health Academy (Starts September 2026)
![[Registration Open] Second Session of the Planetary Health Academy (Starts September 2026)](https://hgpi.org/en/wp-content/uploads/sites/2/HGPI_20260722_PLH-Academy-2.png)
-
2026-07-31
[Policy recommendation] Reliable Policy Implementation for Early Detection and Early Intervention of Chronic Kidney Disease (CKD) (July 31, 2026)
![[Policy recommendation] Reliable Policy Implementation for Early Detection and Early Intervention of Chronic Kidney Disease (CKD) (July 31, 2026)](https://hgpi.org/en/wp-content/uploads/sites/2/ckd-ncd-20260731-top_ENG.png)
-
2026-08-05
[Registration Open] (Webinar) The 4th J-PEP Seminar “The History of PPI in Japan and My Own PPI Journey” (September 30, 2026)
![[Registration Open] (Webinar) The 4th J-PEP Seminar “The History of PPI in Japan and My Own PPI Journey” (September 30, 2026)](https://hgpi.org/en/wp-content/uploads/sites/2/HGPI_20260930_The4th-J-PEPseminar.jpg)
